Home
Hannah Valantine, Director: BridgeBio Pharma BBIO Planned sale · Filed 03/10
Trade details
- Type
- Planned sale notice
- Person
- Hannah ValantineDirector
- Planned sale date
- 26/03/10
- Filed
- 26/03/10
More to sell after $1.7M in 3 months
BridgeBio Pharma trades, last 26 weeks
What else happened in BridgeBio Pharma around then
Filed or reported within 30 days of the trade day · 02/08~04/09Hannah Valantine's recent trades
- Hannah Valantine
Planned sale10b5-1 planCareDx
Planned sale10b5-1 planCareDx
CDNA
$856.2K
28,779 sh
$856.2K
Filed 07/16
Traded 07/16
- Hannah Valantine
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 planBridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/24
Traded 06/22
- Hannah Valantine
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 planBridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/24
Traded 06/23
- Hannah Valantine
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 planBridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/23
Traded 06/23
- Hannah Valantine
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 planBridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/22
Traded 06/22
